pravastatin has been researched along with Familial Combined Hyperlipidemia in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franco, M; Masana, L; Oliván, JJ; Pérez-Jiménez, F; Pintó, X; Plana, N; Ros, E; Sust, M; Videla, S; Villoria, J | 1 |
| Bittolo Bon, G; Calabresi, L; Cattin, L; Fellin, R; Manzato, E; Montagnani, M; Pauciullo, P; Pisciotta, L; Sirtori, CR | 1 |
| Avisar, I; Brook, JG; Wolfovitz, E | 1 |
| Cassinotti, M; D'Acquarica, AL; Franceschini, G; Gianfranceschi, G; Murakami, T; Pazzucconi, F; Sirtori, CR; Sirtori, M; Vecchio, G | 1 |
| Baldo-Enzi, G; Cortella, A; Crepaldi, G; Manzato, E; Sartore, G; Zambon, S | 1 |
| Barter, PJ; Contacos, C; Sullivan, DR | 1 |
| Athyros, VG; Carina, MV; Didangelos, TP; Hatzikonstandinou, HA; Kontopoulos, AG; Kranitsas, DF; Papageorgiou, AA | 1 |
| Ellen, RL; McPherson, R | 1 |
| Athyros, VG; Kontopoulos, AG; Papageorgiou, AA | 1 |
| Athyros, VG; Athyrou, VV; Demitriadis, DS; Kontopoulos, AG; Papageorgiou, AA; Pehlivanidis, AN | 1 |
| Arai, H; Ishii, K; Kawai, C; Kita, T; Kume, N; Nagano, Y; Otani, H; Ueda, Y; Yokode, M | 1 |
1 review(s) available for pravastatin and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia.
Topics: Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Male; Middle Aged; Pravastatin; Risk Factors; Simvastatin; Triglycerides | 1998 |
9 trial(s) available for pravastatin and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate.
Topics: Adolescent; Adult; Aged; Benzenesulfonates; Cholesterol, LDL; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperlipidemia, Familial Combined; Male; Middle Aged; Pilot Projects; Pravastatin; Statistics, Nonparametric | 2004 |
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Double-Blind Method; Female; Heptanoic Acids; Humans; Hyperlipidemia, Familial Combined; Male; Middle Aged; Particle Size; Pravastatin; Pyrroles; Treatment Outcome; Triglycerides | 2005 |
Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia.
Topics: Aged; Atorvastatin; Bezafibrate; Cholesterol, LDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrroles; Treatment Outcome; Triglycerides | 2008 |
Pravastatin effectively lowers LDL cholesterol in familial combined hyperlipidemia without changing LDL subclass pattern.
Topics: Adult; Aged; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, LDL; Female; Glycoproteins; Humans; Hyperlipidemia, Familial Combined; Male; Middle Aged; Phosphatidylcholine-Sterol O-Acyltransferase; Pravastatin | 1994 |
Pravastatin treatment in combined hyperlipidaemia. Effect on plasma lipoprotein levels and size.
Topics: Adult; Aged; Cholesterol; Double-Blind Method; Female; Humans; Hyperlipidemia, Familial Combined; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Pravastatin; Triglycerides | 1994 |
Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia.
Topics: Adult; Aged; Apolipoproteins B; Cholesterol; Cholesterol, LDL; Fatty Acids, Omega-3; Female; Humans; Hyperlipidemia, Familial Combined; Lipids; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Particle Size; Pravastatin; Triglycerides | 1993 |
Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Cholesterol, LDL; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Pravastatin; Simvastatin; Treatment Outcome | 1997 |
Statin-fibrate combinations in patients with combined hyperlipedemia.
Topics: Clofibric Acid; Coronary Disease; Drug Therapy, Combination; Fibric Acids; Follow-Up Studies; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Myocardial Infarction; Pravastatin; Simvastatin; Stroke | 2001 |
Atorvastatin versus four statin-fibrate combinations in patients with familial combined hyperlipidaemia.
Topics: Adult; Aged; Atorvastatin; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Lipids; Male; Middle Aged; Pravastatin; Prospective Studies; Pyrroles; Simvastatin; Time Factors | 2002 |
1 other study(ies) available for pravastatin and Familial Combined Hyperlipidemia
| Article | Year |
|---|---|
Lipoproteins and atherosclerosis.
Topics: Animals; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholesterol Esters; Cholestyramine Resin; Disease Models, Animal; Foam Cells; Heptanoic Acids; Hyperlipidemia, Familial Combined; Lipoproteins, LDL; Liver; Macrophages; Mice; Naphthalenes; Pravastatin; Probucol; Rabbits; Receptors, Cell Surface; Receptors, Lipoprotein | 1990 |